GSK
777 hedge funds and large institutions have $10.8B invested in GSK in 2018 Q1 according to their latest regulatory filings, with 100 funds opening new positions, 290 increasing their positions, 251 reducing their positions, and 82 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
777
Holders Change
+15
Holders Change %
+1.97%
% of All Funds
17.83%
Holding in Top 10
15
Holding in Top 10 Change
+6
Holding in Top 10 Change %
+66.67%
% of All Funds
0.34%
New
100
Increased
290
Reduced
251
Closed
82
Calls
$133M
Puts
$168M
Net Calls
-$35M
Net Calls Change
-$42.2M
Top Buyers
Top Sellers
| 1 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
$832M |
| 2 |
Two Sigma Advisers
New York
|
$88.4M |
| 3 |
MWNA
Marshall Wace North America
New York
|
$20.3M |
| 4 |
Renaissance Technologies
New York
|
$317M |
| 5 |
Two Sigma Investments
New York
|
$34.1M |
